Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3490)
ROCKET PHARMACEUTICALS, INC. (RCKT)
Wilson Martin — General Counsel
Shares
3,493
Price
$3.38
Total Value
$11.81K
Shares Held After
674,484
% of Holdings
0.5%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Shah Gaurav — CEO
Shares
2,837
Price
$3.38
Total Value
$9.59K
Shares Held After
1,058,887
% of Holdings
0.3%
4D Molecular Therapeutics, Inc. (FDMT)
Bizily Scott — Chief Legal Officer
Shares
1,635
Price
$12.00
Total Value
$19.62K
Shares Held After
8,617
% of Holdings
15.9%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Shulman Joseph — Chief Technical Officer
Shares
5,079
Price
$119.75
Total Value
$608.21K
Shares Held After
15,915
% of Holdings
24.2%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Garfield Alastair — Chief Scientific Officer
Shares
800
Price
$119.17
Total Value
$95.34K
Shares Held After
2,295
% of Holdings
25.8%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Garfield Alastair — Chief Scientific Officer
Shares
3,400
Price
$118.28
Total Value
$402.17K
Shares Held After
3,095
% of Holdings
52.3%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Garfield Alastair — Chief Scientific Officer
Shares
1,556
Price
$117.08
Total Value
$182.17K
Shares Held After
6,495
% of Holdings
19.3%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Garfield Alastair — Chief Scientific Officer
Shares
2,007
Price
$116.11
Total Value
$233.03K
Shares Held After
8,051
% of Holdings
20.0%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP&CFO
Shares
1,772
Price
$59.14
Total Value
$104.80K
Shares Held After
0
% of Holdings
100.0%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP&CFO
Shares
9,230
Price
$58.59
Total Value
$540.75K
Shares Held After
1,772
% of Holdings
83.9%
Dyne Therapeutics, Inc. (DYN)
Lucera Erick — Chief Financial Officer
Shares
1,797
Price
$26.28
Total Value
$47.23K
Shares Held After
119,766
% of Holdings
1.5%
VERU INC. (VERU)
BARNETTE K GARY — Chief Scientific Officer
Shares
1,800
Price
$2.69
Total Value
$4.84K
Shares Held After
2,300
% of Holdings
78.3%
Dyne Therapeutics, Inc. (DYN)
Cox John — Director
Shares
4,986
Price
$26.28
Total Value
$131.03K
Shares Held After
363,165
% of Holdings
1.4%
Dyne Therapeutics, Inc. (DYN)
Kerr Douglas — Chief Medical Officer
Shares
1,556
Price
$26.28
Total Value
$40.89K
Shares Held After
167,599
% of Holdings
0.9%
Cue Biopharma, Inc. (CUE)
Lin Shao-Lee — Director
Shares
10,460
Price
$29.48
Total Value
$308.36K
Shares Held After
705,995
% of Holdings
1.5%
Cue Biopharma, Inc. (CUE)
Lin Shao-Lee — Director
Shares
2,375
Price
$28.11
Total Value
$66.76K
Shares Held After
716,455
% of Holdings
0.3%
Cue Biopharma, Inc. (CUE)
Lin Shao-Lee — Director
Shares
5,423
Price
$27.19
Total Value
$147.45K
Shares Held After
718,830
% of Holdings
0.7%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Lee Jennifer Kayden — EVP, Head of North America
Shares
75,834
Price
$117.38
Total Value
$8.90M
Shares Held After
0
% of Holdings
100.0%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
2,358
Price
$108.46
Total Value
$255.76K
Shares Held After
15,312
% of Holdings
13.3%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
2,142
Price
$107.71
Total Value
$230.72K
Shares Held After
17,670
% of Holdings
10.8%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
1,268
Price
$106.63
Total Value
$135.20K
Shares Held After
19,812
% of Holdings
6.0%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
2,132
Price
$105.57
Total Value
$225.08K
Shares Held After
21,080
% of Holdings
9.2%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
2,100
Price
$104.67
Total Value
$219.81K
Shares Held After
23,212
% of Holdings
8.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$512.36
Total Value
$122.97K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$511.12
Total Value
$81.78K
Shares Held After
324,683
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$509.92
Total Value
$101.98K
Shares Held After
324,843
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
640
Price
$508.76
Total Value
$325.61K
Shares Held After
325,043
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
920
Price
$507.14
Total Value
$466.57K
Shares Held After
325,683
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,679
Price
$506.16
Total Value
$849.84K
Shares Held After
326,603
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
961
Price
$505.18
Total Value
$485.48K
Shares Held After
328,282
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$503.83
Total Value
$80.61K
Shares Held After
329,243
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$502.93
Total Value
$221.29K
Shares Held After
329,403
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,519
Price
$501.88
Total Value
$762.35K
Shares Held After
329,843
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,328
Price
$500.93
Total Value
$665.24K
Shares Held After
331,362
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,253
Price
$500.08
Total Value
$626.60K
Shares Held After
332,690
% of Holdings
0.4%
Edgewise Therapeutics, Inc. (EWTX)
Donovan Joanne M. — CMO
Shares
2,919
Price
$43.41
Total Value
$126.70K
Shares Held After
8,625
% of Holdings
25.3%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D&CMO
Shares
16,142
Price
$27.61
Total Value
$445.62K
Shares Held After
0
% of Holdings
100.0%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
1,900
Price
$0.92
Total Value
$1.75K
Shares Held After
375,785
% of Holdings
0.5%
Altimmune, Inc. (ALT)
Durso Jerome Benedict — Director
Shares
15,000
Price
$2.95
Total Value
$44.25K
Shares Held After
62,500
% of Holdings
24.0%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
951
Price
$71.50
Total Value
$68.00K
Shares Held After
494,887
% of Holdings
0.2%
Vericel Corp (VCEL)
MCLAUGHLIN KEVIN F — Director
Shares
7,000
Price
$44.53
Total Value
$311.71K
Shares Held After
18,300
% of Holdings
27.7%
Cue Biopharma, Inc. (CUE)
Lin Shao-Lee — Director
Shares
5,775
Price
$27.75
Total Value
$160.26K
Shares Held After
724,253
% of Holdings
0.8%
Cue Biopharma, Inc. (CUE)
Lin Shao-Lee — Director
Shares
34,225
Price
$26.99
Total Value
$923.73K
Shares Held After
730,028
% of Holdings
4.5%
Outlook Therapeutics, Inc. (OTLK)
Sukhtian Ghiath M. — Director
Shares
2,525,252
Price
$0.99
Total Value
$2.50M
Shares Held After
24,617,320
% of Holdings
10.3%
Disc Medicine, Inc. (IRON)
Yu Jonathan Yen-Wen — Chief Operating Officer
Shares
804
Price
$82.64
Total Value
$66.44K
Shares Held After
54,324
% of Holdings
1.5%
Tectonic Therapeutic, Inc. (TECX)
McNamara Peter — Chief Scientific Officer
Shares
43
Price
$35.00
Total Value
$1.50K
Shares Held After
55,285
% of Holdings
0.1%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Mazabraud Yann — EVP, Head of International
Shares
17,319
Price
$117.47
Total Value
$2.03M
Shares Held After
55,655
% of Holdings
23.7%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Mazabraud Yann — EVP, Head of International
Shares
18,208
Price
$116.49
Total Value
$2.12M
Shares Held After
72,974
% of Holdings
20.0%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Mazabraud Yann — EVP, Head of International
Shares
14,568
Price
$115.43
Total Value
$1.68M
Shares Held After
91,182
% of Holdings
13.8%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Mazabraud Yann — EVP, Head of International
Shares
3,605
Price
$114.70
Total Value
$413.48K
Shares Held After
105,750
% of Holdings
3.3%
Showing 201–250 of 3490 transactions (page 5 of 70)